Vaccine stocks hit by Robert Kennedy Jr nomination

Investors reacted negatively to Donald Trump’s nomination of vaccine skeptic Robert F Kennedy Jr as the top US health official, causing shares in vaccine makers and pharmaceutical companies to plummet. Kennedy’s controversial views on vaccines and plans to downsize the FDA led to concerns within the industry, impacting stocks across the pharmaceutical sector. Despite the sell-off, some experts believe that Kennedy’s extreme ideas may not become policy, with other cabinet appointees advocating for reducing barriers to drug approval.

Full Article